Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells

Tumor hypoxia is one main biological factor that drives resistance to chemotherapy and radiotherapy. To develop a novel strategy for overcoming hypoxia-induced therapy resistance, we examined the anti-neoplastic activity of the reactive oxygen donor dihydroartemisinin (DHA) in human colon cancer cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Ontikatze, Teona, Rudner, Justine, Handrick, René, Belka, Claus, Jendrossek, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032948/
https://www.ncbi.nlm.nih.gov/pubmed/24904829
http://dx.doi.org/10.3389/fonc.2014.00116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032948/
https://www.ncbi.nlm.nih.gov/pubmed/24904829
http://dx.doi.org/10.3389/fonc.2014.00116

Ejemplares similares